tiprankstipranks
Trending News
More News >
Ametek Inc (AME)
NYSE:AME

Ametek (AME) AI Stock Analysis

Compare
701 Followers

Top Page

AME

Ametek

(NYSE:AME)

Select Model
Select Model
Select Model
Outperform 79 (OpenAI - 5.2)
Rating:79Outperform
Price Target:
$268.00
â–²(12.03% Upside)
Action:ReiteratedDate:02/20/26
AME scores well primarily due to strong financial performance (high, durable margins and conservative leverage) and a very positive earnings outlook with record operating momentum and confident 2026 guidance. Technicals add support with a clear uptrend and positive momentum. The main offset is valuation: a high P/E and low dividend yield reduce the overall score by limiting upside if execution softens.
Positive Factors
High, stable margins
AMETEK’s sustained TTM gross (~36%) and net (~20%) margins indicate durable earnings power across cycles. Consistently strong margins support reinvestment, R&D, and shareholder returns, and give the company buffer to absorb cyclical pressure or integration costs while maintaining profitability.
Strong free cash flow generation
Robust free cash flow and exceptionally high conversion (FY ~113%, Q4 132%) provide durable funding for acquisitions, buybacks, dividends and R&D. Management’s guidance of 110–115% conversion and modest capex (~2% of sales) implies persistent cash-generation capacity supporting long-term capital allocation.
Diversified markets and active M&A capacity
Broad end-market exposure, a record backlog and an active, disciplined M&A program plus >$5B deployment capacity give AMETEK structural growth optionality. Diversification across instruments and electromechanical markets reduces single-market risk and supports steady multi-year revenue expansion.
Negative Factors
Acquisition-related margin dilution
Recent deals include lower-margin businesses (e.g., FARO) that dilute reported margins and require restructuring spend. The multi-year path to target margins and integration charges can depress near-term reported profitability and make delivery of margin guidance hinge on successful, sustained operational improvements.
Rising depreciation & acquisition amortization
Elevated D&A and substantial acquisition-related amortization materially increase non-cash charges against GAAP earnings. This compresses reported EPS growth, complicates year-over-year comparatives, and can mask underlying operating performance despite strong cash generation and organic improvement.
Operating cash flow conversion volatility
A sharp drop in operating cash flow coverage signals working-capital timing or conversion variability. If persistent, such volatility could strain near-term liquidity for M&A, dividends or buybacks, and increase reliance on external financing despite strong headline free cash flow.

Ametek (AME) vs. SPDR S&P 500 ETF (SPY)

Ametek Business Overview & Revenue Model

Company DescriptionAMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices worldwide. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets. This segment also provides power quality monitoring and metering devices, uninterruptible power supplies, programmable power equipment, electromagnetic compatibility test equipment, gas turbines, and environmental health and safety market sensors, dashboard instruments for heavy trucks and other vehicles, and instrumentation and controls for the food and beverage industries; and aircraft and engine sensors, monitoring systems, power supplies, fuel and fluid measurement systems, and data acquisition systems for the aerospace industry. Its EMG segment offers engineered electrical connectors and electronics packaging to protect sensitive devices and mission-critical electronics; precision motion control products for data storage, medical devices, business equipment, automation, and other applications; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for use in thermal management, military, commercial aircraft, and military ground vehicles; and motors for use in commercial appliances, fitness equipment, food and beverage machines, hydraulic pumps, and industrial blowers. This segment also operates a network of aviation maintenance, repair, and overhaul facilities. In addition, the company offers clinical and educational communication solutions. AMETEK, Inc. was founded in 1930 and is headquartered in Berwyn, Pennsylvania.
How the Company Makes MoneyAmetek generates revenue primarily through the sale of its electronic instruments and electromechanical devices. The company operates on a diversified revenue model that includes direct sales to customers, distribution through third-party channels, and long-term contracts with various industries. Key revenue streams include sales from instrumentation products, which are often critical for testing and measuring in various industrial processes, and electromechanical devices used in applications ranging from aerospace to energy generation. Additionally, Ametek benefits from strategic acquisitions that enhance its product offerings and expand its market reach. Partnerships with major industrial players and investments in research and development also contribute to its ability to innovate and maintain a competitive edge, driving consistent revenue growth.

Ametek Key Performance Indicators (KPIs)

Any
Any
Revenue by Product
Revenue by Product
Shows how much revenue each product line generates, highlighting which products are driving growth and which may need strategic adjustments.
Chart InsightsAMETEK's Aerospace and Power segment shows consistent growth, reflecting strong demand and strategic positioning. The Automation and Engineered Solutions segment has rebounded significantly since 2023, driven by new product innovations and successful acquisitions like FARO Technologies. However, the Process and Analytical Instrumentation segment faces challenges, with organic sales slightly down due to trade uncertainties, as noted in the earnings call. Despite these hurdles, AMETEK's overall performance is robust, with record sales and increased earnings guidance, highlighting effective strategic acquisitions and operational efficiency.
Data provided by:The Fly

Ametek Earnings Call Summary

Earnings Call Date:Feb 03, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 05, 2026
Earnings Call Sentiment Positive
The call was strongly positive: management reported multiple quarterly and annual records (sales, orders, operating income, EBITDA, EPS, and cash flow), improving margins, robust free cash flow and a record backlog, and they provided constructive 2026 guidance (high-single-digit top-line, mid-single-digit organic growth, and EPS +6–9%). Challenges are manageable and largely relate to integration and near-term dilution from recent acquisitions (notably FARO), higher amortization and an elevated tax rate, plus some end-market variability earlier in the year. Given the scale of record results, strong cash conversion, disciplined capital allocation and an active M&A pipeline, the positive operational and financial momentum outweigh the integration- and tax-related headwinds.
Q4-2025 Updates
Positive Updates
Record Quarterly and Annual Financial Results
Q4 sales reached a record $2.0B, up 13% year-over-year; full-year 2025 sales were $7.4B, up 7% versus 2024. The company established records for sales, orders, operating income, EBITDA, diluted EPS, operating cash flow and free cash flow in the quarter and set annual records for sales, operating income, operating margin, EBITDA and diluted EPS.
Strong Orders, Backlog and Organic Momentum
Q4 orders were a record $2.0B, up 18% year-over-year (organic orders +7%), producing a record backlog of $3.58B. Management reported improving sales and orders growth throughout 2025 with the strongest quarter in Q4 and continued solid order activity into January.
Profitability and Margin Expansion
Q4 operating income was a record $523M, up 12% year-over-year. Q4 operating margin was 26.2% and core operating margin 27.6% (core margins +100 bps in the quarter). Full-year core margins were up ~80 bps and EBITDA for the quarter was $618M (+10% YoY) with a 30.9% EBITDA margin.
Record Cash Generation and Strong Cash Conversion
Q4 free cash flow was a record $527M, up 6% YoY, with quarterly free cash flow to net income conversion of 132%. Full-year 2025 free cash flow was $1.7B with conversion of 113% of net income; 2026 conversion is guided at 110–115%.
Earnings Per Share Execution
Q4 diluted EPS was a record $2.01, up 7% YoY and above guidance; adjusted for an abnormally low prior-year tax rate, EPS grew ~11% on a 5% organic sales increase. Full-year 2025 diluted EPS was $7.43, up 9% versus the prior year.
Segment-Level Strength — EMG
Electromechanical Group (EMG) Q4 sales were $629M (+15% YoY) with organic sales +14%. EMG operating income was $142.5M (+28% YoY) and operating margins expanded to 22.7% (+240 bps YoY). Management noted broad-based double-digit organic growth across EMG divisions in Q4.
Segment-Level Strength — EIG Improvements
Electronic Instruments Group (EIG) Q4 sales were $1.37B (+13% YoY); organic sales were positive at +2% in Q4 (improvement through the year). EIG operating income was a record $413.7M (+7% YoY) and core operating margins improved to 32.3% (+50 bps).
Geographic and End‑market Diversification
Geographic growth: Asia up 10% (China low double-digits), US and international up mid-single digits. Aerospace & defense delivered low double-digit growth in the quarter and is expected to produce high single-digit organic growth in 2026. Process, power and automation businesses showed improving trends.
Active, Disciplined Capital Deployment
2025 capital deployment included acquisitions (Ferro, Kern), $443M of share repurchases, and dividends; the firm deployed >$1.8B and retains capacity to deploy >$5B while preserving an investment-grade rating. Management reiterated M&A as top priority and a strong pipeline.
Innovation Investment and Product Vitality
Incremental R&D/engineering/sales investments of $90M in 2025 (guiding $100M incremental in 2026). Vitality index (sales from new products over last 3 years) was 30% in Q4, highlighting strong new-product contribution and commercial traction (e.g., Spectro new product family).
Negative Updates
Acquisition-Related Margin Dilution and Integration Costs
Recent acquisitions (notably FARO and other add-ons) are lower-margin businesses creating near-term reported-margin dilution; FARO currently at mid‑teens EBITDA margin with one-time restructuring/integration charges of ~$17.6M and management projecting multiple years to reach target margins (~30%).
Tax Rate Increase and Future Tax Guidance
Effective tax rate rose to 16.3% in Q4 from 12.8% in 2024 (full-year 17.8%). Management expects the 2026 effective tax rate to be ~18.5–19.5%, which unfavorably impacts EPS comparatives versus adjusted prior periods.
Rising Depreciation/Amortization and Acquisition-Related Amortization
Full-year depreciation and amortization was $1.423B. For 2026, D&A is expected to be ~$430M, including after-tax acquisition-related intangible amortization of ~$210M (approx. $0.91 per diluted share), pressuring GAAP earnings metrics.
Higher Leverage from Recent Deals
Total debt increased to $2.3B (up $200M YoY) due to the Ferro acquisition; cash on hand was $458M. While leverage ratios remain conservative (gross debt/EBITDA ~1.0x, net ~0.8x), near-term balance-sheet utilization increased due to M&A.
Segment and Market Headwinds Earlier in the Year
Process businesses experienced negative or sluggish organic growth earlier in 2025 before improving to low-single-digit organic growth in Q4; certain end-markets (research, oil & gas) remain weaker and could temper process segment recovery.
Incremental Expense Increases and One-Time Items
Q4 G&A increased by $4M (noted charitable donations) and full-year G&A was up $10M; other expenses were $6M higher year-over-year in Q4. Management expects other operating expenses in 2026 to be largely in line with 2025 levels but flagged near-term variability.
Near-Term Margin Conservatism in Guidance
Management guided to modest margin expansion for 2026 (approximately +30 bps on core margins) and lowered expected reported incremental margins (management cited a conservative 35% incremental margin vs. stronger quarterly incrementals in 2025), reflecting integration and comp pressures.
Macro and Geopolitical Risks
Management acknowledged ongoing macroeconomic uncertainty (deglobalization/tariff dynamics, real estate hangover in China) and noted that while they see improving demand, conversion of backlog into shipments can vary (conversion historically ~30–50%).
Company Guidance
AMETEK guided 2026 to overall sales up to high-single-digits with organic sales up low- to mid-single-digits, diluted EPS of $7.87–$8.07 (up ~6%–9% YoY), and Q1 sales ~+10% with adjusted Q1 EPS $1.90–$1.95 (up ~6%–9%); the company expects ~30 basis points of margin expansion for the year with reported incremental margins targeted near 35%, an effective tax rate of 18.5%–19.5%, G&A ≈1.5% of sales, other operating expenses roughly in line with 2025, capex ≈$160M (~2% of sales), depreciation & amortization ≈$430M (including ~$210M of after‑tax acquisition‑related intangible amortization, ≈$0.91/sh), free cash flow conversion of 110%–115% of net income, a $100M incremental investment program, and financial capacity to deploy >$5B while maintaining investment‑grade (year‑end gross debt/EBITDA ~1.0x; net ~0.8x).

Ametek Financial Statement Overview

Summary
Strong and consistent profitability (TTM gross margin ~36% and net margin ~20%) and steady multi-year revenue growth to $7.40B TTM support a high score. Balance sheet leverage is conservative and improving (debt-to-equity ~0.21). Main watch items are slowing recent growth and weaker near-term cash conversion (operating cash flow coverage down to ~0.43 TTM).
Income Statement
86
Very Positive
Revenue has grown steadily from $4.54B (2020) to $7.40B in TTM (Trailing-Twelve-Months), though the pace has moderated recently (TTM revenue growth: 3.3%). Profitability is a clear strength: TTM gross margin is ~36.3% and net margin is ~20.0%, both consistently strong across the period, supporting durable earnings power. A minor watch item is that EBITDA margin in TTM (~28.3%) is below the 2023–2024 level (~30–31%), suggesting some incremental cost pressure or mix shift despite continued earnings growth.
Balance Sheet
84
Very Positive
Leverage is conservative and improving: debt-to-equity is ~0.21 in TTM (Trailing-Twelve-Months), down meaningfully versus 2020–2023 (~0.34–0.41). Equity has expanded alongside assets (TTM equity ~$10.63B; assets ~$16.07B), indicating a stronger capital base over time. Returns remain healthy and stable, with return on equity around ~14–15% across periods. The main risk is that total debt is still sizable in absolute dollars (~$2.28B TTM), which matters more if growth slows or financing costs rise, even though ratios look comfortable.
Cash Flow
80
Positive
Cash generation is strong and high quality: TTM free cash flow is ~$1.67B and closely tracks net income (free cash flow to net income ~0.94 TTM), which supports flexibility for reinvestment and shareholder returns. Free cash flow has also grown over time (TTM free cash flow growth: 1.8%), albeit at a slower rate recently. A key weakness is volatility in cash conversion versus earnings as shown by the operating cash flow coverage ratio (down to ~0.43 in TTM from ~0.87 in 2024), implying near-term working-capital or timing headwinds even though full-year cash flow remains robust.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue7.40B6.94B6.60B6.15B5.55B
Gross Profit2.69B2.48B2.38B2.15B1.91B
EBITDA1.88B2.16B2.03B1.83B1.60B
Net Income1.48B1.38B1.31B1.16B990.05M
Balance Sheet
Total Assets16.07B14.63B15.02B12.43B11.90B
Cash, Cash Equivalents and Short-Term Investments457.95M374.00M409.80M345.39M346.77M
Total Debt2.28B2.32B3.37B2.56B2.72B
Total Liabilities5.44B4.98B6.29B4.95B5.03B
Stockholders Equity10.63B9.66B8.73B7.48B6.87B
Cash Flow
Free Cash Flow1.67B1.70B1.60B1.01B1.05B
Operating Cash Flow1.80B1.83B1.74B1.15B1.16B
Investing Cash Flow-1.06B-244.81M-2.38B-552.76M-2.06B
Financing Cash Flow-686.32M-1.60B697.28M-575.70M39.34M

Ametek Technical Analysis

Technical Analysis Sentiment
Positive
Last Price239.22
Price Trends
50DMA
219.93
Positive
100DMA
206.20
Positive
200DMA
193.99
Positive
Market Momentum
MACD
4.75
Positive
RSI
66.13
Neutral
STOCH
82.12
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AME, the sentiment is Positive. The current price of 239.22 is above the 20-day moving average (MA) of 232.09, above the 50-day MA of 219.93, and above the 200-day MA of 193.99, indicating a bullish trend. The MACD of 4.75 indicates Positive momentum. The RSI at 66.13 is Neutral, neither overbought nor oversold. The STOCH value of 82.12 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AME.

Ametek Risk Analysis

Ametek disclosed 18 risk factors in its most recent earnings report. Ametek reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Ametek Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$127.38B36.8125.79%0.79%0.22%26.66%
79
Outperform
$54.78B37.3814.59%0.59%3.67%10.44%
72
Outperform
$83.76B27.7193.75%2.43%-0.41%-10.88%
70
Outperform
$36.00B24.637.93%0.73%13.95%6.80%
69
Neutral
$84.77B36.8211.31%1.58%2.97%18.14%
68
Neutral
$45.78B46.6227.71%1.33%0.98%-7.51%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AME
Ametek
239.22
53.92
29.10%
EMR
Emerson Electric Company
150.75
35.50
30.80%
ITW
Illinois Tool Works
290.63
33.17
12.88%
PH
Parker Hannifin
1,009.18
364.58
56.56%
ROK
Rockwell Automation
407.45
133.03
48.48%
ROP
Roper Technologies
349.73
-232.23
-39.91%

Ametek Corporate Events

Business Operations and StrategyDividends
Ametek Announces 10% Increase in Quarterly Dividend
Positive
Feb 12, 2026

On February 12, 2026, AMETEK, Inc. announced that its board approved a 10% increase in the quarterly cash dividend on common stock, raising the payout to $0.34 per share from $0.31, with the first higher dividend payable on March 31, 2026 to shareholders of record as of March 16, 2026. The move lifts the indicated annual dividend rate to $1.36 per share and underscores the company’s strong financial position, robust cash generation, and strategy of balancing capital deployment between strategic acquisitions and steadily rising shareholder returns.

The most recent analyst rating on (AME) stock is a Hold with a $245.00 price target. To see the full list of analyst forecasts on Ametek stock, see the AME Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
AMETEK Delivers Record 2025 Results and Confident 2026 Outlook
Positive
Feb 3, 2026

On February 3, 2026, AMETEK reported record results for the fourth quarter and full year 2025, with quarterly sales reaching $2.0 billion, up 13% year-on-year, and adjusted earnings per share rising 7% to $2.01. GAAP and adjusted operating income, operating cash flow, and free cash flow all hit record levels, driving a 132% free cash flow to net income conversion and underscoring strong contributions from organic growth, recent acquisitions, and margin expansion across both the Electronic Instruments Group and Electromechanical Group. For 2025, sales grew 7% to $7.4 billion, while adjusted EPS increased 9% to $7.43, and the company set annual records across sales, profit, margins, EBITDA, and earnings per share. Management highlighted a record backlog, improving end-market conditions, and ample financial flexibility as it entered 2026, and projected mid- to high-single-digit sales growth and a further 6% to 9% increase in adjusted EPS for the year, signaling continued confidence in AMETEK’s acquisition-driven and organically funded growth strategy.

The most recent analyst rating on (AME) stock is a Buy with a $256.00 price target. To see the full list of analyst forecasts on Ametek stock, see the AME Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 20, 2026